Experienced in Hereditary Alpha-Tryptasemia

Chiara Elena

Pavia, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Hereditary Alpha-Tryptasemia
Pavia, IT 
OverviewLocationsClinical Research

Overview

Chiara Elena practices in Pavia, Italy. Ms. Elena is rated as an Experienced expert by MediFind in the treatment of Hereditary Alpha-Tryptasemia. Her top areas of expertise are Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Chronic Myelogenous Leukemia (CML), Leukemia, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 99 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hereditary Alpha-Tryptasemia.

Gender
Female

Locations

Pavia, Italy
Other Locations
Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
Enrollment Status: Recruiting
Publish Date: April 30, 2025
Intervention Type: Drug
Study Drug: BLU-263
Study Phase: Phase 2/Phase 3
An International Field Study for the Reliability and Validity of the Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia (EORTC QLQ-CML24)
An International Field Study for the Reliability and Validity of the Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia (EORTC QLQ-CML24)
Enrollment Status: Unknown
Publish Date: March 21, 2019
View 1 Less Clinical Trial

99 Total Publications

A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.
Journal: Blood
Published: April 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Elena's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile